Subsequent Event	12 Months Ended
Sep. 30, 2015
Subsequent Event.
Subsequent Event	22. Subsequent Event Dr. Organic Limited In August 2015, NBTY (2015) Limited, a private limited company incorporated in England and Wales and an indirect subsidiary of Holdings ("NBTY (2015)"), and Holland & Barrett Group Limited, a company incorporated in England and Wales and an indirect subsidiary of Alphabet Holding Company, Inc. ("H&B") entered into an agreement to purchase Dr. Organic Limited (the "Share Purchase Agreement") pursuant to which NBTY (2015) agreed to acquire all of the ordinary shares in Dr. Organic Limited, a manufacturer, marketer and distributor of a broad line of naturally-inspired personal care products. The purchase price for the ordinary shares of Dr. Organic Limited is approximately £53,000 ($83,000), payable in (i) cash of £33,000 ($50,000) (the "cash consideration"), (ii) loan notes in an aggregate principal amount of approximately £20,000 ($30,000) (the "completion loan notes") to be issued by NBTY (2015) to the sellers, which mature 18 months after issuance and are redeemable at any time after six months at the option of the holders, (iii) 399,000 class B ordinary shares, par value £0.01 (the "rollover shares"), to be issued by NBTY (2015) to the sellers and (iv) 100,000 class C ordinary shares, par value £0.01, to be issued by NBTY (2015) to certain of the sellers at a premium of £0.04 each (which will be redeemed by NBTY (2015) for £0.05 each 18 months after issuance), each payable or issued on the closing date of the acquisition. Holders of the rollover shares may require us to repurchase them for an amount based on the future earnings of Dr. Organic Limited and its subsidiaries (the "repurchase amount"), which amount is payable, at the election of holders, in cash or through the issuance of loan notes by NBTY (2015) with terms similar to the completion loan notes. To the extent the holders do not exercise their put right, we will have the right to call the rollover shares at the repurchase amount. The completion of the transaction is subject to certain closing conditions, including regulatory clearance in the United Kingdom. The closing of the Dr. Organic Limited acquisition is expected to occur during the second half of calendar 2015.

22. Subsequent Event

Dr. Organic Limited

In August 2015, NBTY (2015) Limited, a private limited company incorporated in England and Wales and an indirect subsidiary of Holdings ("NBTY (2015)"), and Holland & Barrett Group Limited, a company incorporated in England and Wales and an indirect subsidiary of Alphabet Holding Company, Inc. ("H&B") entered into an agreement to purchase Dr. Organic Limited (the "Share Purchase Agreement") pursuant to which NBTY (2015) agreed to acquire all of the ordinary shares in Dr. Organic Limited, a manufacturer, marketer and distributor of a broad line of naturally-inspired personal care products.

The purchase price for the ordinary shares of Dr. Organic Limited is approximately £53,000 ($83,000), payable in (i) cash of £33,000 ($50,000) (the "cash consideration"), (ii) loan notes in an aggregate principal amount of approximately £20,000 ($30,000) (the "completion loan notes") to be issued by NBTY (2015) to the sellers, which mature 18 months after issuance and are redeemable at any time after six months at the option of the holders, (iii) 399,000 class B ordinary shares, par value £0.01 (the "rollover shares"), to be issued by NBTY (2015) to the sellers and (iv) 100,000 class C ordinary shares, par value £0.01, to be issued by NBTY (2015) to certain of the sellers at a premium of £0.04 each (which will be redeemed by NBTY (2015) for £0.05 each 18 months after issuance), each payable or issued on the closing date of the acquisition. Holders of the rollover shares may require us to repurchase them for an amount based on the future earnings of Dr. Organic Limited and its subsidiaries (the "repurchase amount"), which amount is payable, at the election of holders, in cash or through the issuance of loan notes by NBTY (2015) with terms similar to the completion loan notes. To the extent the holders do not exercise their put right, we will have the right to call the rollover shares at the repurchase amount.

The completion of the transaction is subject to certain closing conditions, including regulatory clearance in the United Kingdom. The closing of the Dr. Organic Limited acquisition is expected to occur during the second half of calendar 2015.